Keywords: Biosimilars, Development, Guidelines, EGA

Crucial need for global development of biosimilars, says head of European generics group

Article | 20 April 2012

“The need for a framework which allows global biosimilars development is now crucial,” argued European Generic Medicines Association ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in